CXCL16 and acute respiratory distress syndrome: Based on these results, and with the aim of having a unique minimal panel useful for any of the situations mentioned above, we tested a panel with three BMs (RAGE, CXCL16 and Ang-2) and a clinical marker (PaO2/FiO2) to predict ARDS in all groups of patients.